Tina Bagratuni Selected Research

Tina Bagratuni Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 03/2011
9	Multiple Myeloma 12/2021 - 09/2013
6	COVID-19 11/2023 - 01/2021
5	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 12/2018
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 12/2018
2	Infections 11/2023 - 01/2023
2	Amyloidosis 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Disease Progression 10/2020 - 12/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Monoclonal Gammopathy of Undetermined Significance 11/2022
1	Thyroid Diseases (Thyroid Disease) 01/2022
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Liver Diseases (Liver Disease) 01/2019
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019
1	Hepatomegaly 01/2019
1	Familial Amyloidosis (Hereditary Amyloidosis) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Immunoglobulin Light-chain Amyloidosis 12/2018
1	Bone Diseases (Bone Disease) 11/2018
1	Hypercalcemia (Milk Alkali Syndrome) 11/2018
1	Bone Resorption 11/2018
1	Osteolysis 11/2018
1	Osteonecrosis (Kienbock's Disease) 10/2017
1	Venous Thromboembolism 09/2013
1	Thrombosis (Thrombus) 09/2013

Drug/Important Bio-Agent (IBA)

5	BNT162 VaccineIBA 01/2023 - 01/2021
5	Immunoglobulin M (IgM)IBA 01/2023 - 12/2018
4	Neutralizing AntibodiesIBA 11/2023 - 01/2021
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2013
3	mRNA VaccinesIBA 01/2023 - 01/2021
3	VaccinesIBA 01/2023 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2018
3	Cell-Free Nucleic AcidsIBA 11/2022 - 12/2018
2	AntibodiesIBA 11/2023 - 01/2022
2	ChemokinesIBA 01/2023 - 10/2021
2	CytokinesIBA 01/2023 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2021
2	Proteasome InhibitorsIBA 10/2020 - 12/2017
2	Toll-Like Receptor 4IBA 01/2019 - 01/2016
2	Lenalidomide (CC 5013)FDA Link 12/2018 - 09/2013
1	Amino Acids FDA Link 01/2022
1	Thyroid HormonesIBA 01/2022
1	CeramidesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	AntigensIBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 10/2020
1	Immunomodulating AgentsIBA 10/2020
1	Alkylating AgentsIBA 10/2020
1	PlatinumIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	EnzymesIBA 01/2019
1	Muramidase (Lysozyme)IBA 01/2019
1	Prealbumin (Transthyretin)IBA 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	GelsolinIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Apolipoprotein C-II (ApoC2)IBA 01/2019
1	Cystatin CIBA 01/2019
1	CalciumIBA 11/2018
1	CD100 antigenIBA 11/2018
1	plexinIBA 11/2018
1	Bortezomib (Velcade)FDA Link 12/2017
1	CaspasesIBA 12/2017
1	carfilzomibIBA 12/2017
1	Zoledronic Acid (Zometa)FDA Link 10/2017
1	Endothelial Protein C ReceptorIBA 09/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013
1	Adenosine Triphosphate (ATP)IBA 03/2011

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2013
2	Drug Therapy (Chemotherapy) 10/2020 - 07/2013
1	Salvage Therapy 12/2018